Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | ---- | 102.80%67.09B | ---- | ---- | ---- | -80.21%33.08B | ---- | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | 15.68%-6.32B | ---- | ---- | ---- | -39.37%-7.49B | ---- | ---- |
| Interest expense - adjustment | ---- | ---- | ---- | -14.88%3.06B | ---- | ---- | ---- | -2.39%3.59B | ---- | ---- |
| Dividend (income)- adjustment | ---- | ---- | ---- | 7.04%-40.59M | ---- | ---- | ---- | -74.31%-43.67M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | -5.39%-4.94B | ---- | ---- | ---- | -102.88%-4.69B | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | 134.80%78.35M | ---- | ---- | ---- | -730.36%-225.16M | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | 134.80%78.35M | ---- | ---- | ---- | -730.36%-225.16M | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | -352.25%-25.78M | ---- | ---- | ---- | -110.15%-5.7M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | -352.25%-25.78M | ---- | ---- | ---- | -110.15%-5.7M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | -27.52%-119.1M | ---- | ---- | ---- | 85.04%-93.4M | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | --14.04M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | -42.55%-133.14M | ---- | ---- | ---- | 76.02%-93.4M | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | ---- | -4.32%18.64B | ---- | ---- | ---- | -4.68%19.48B | ---- | ---- |
| -Amortization of intangible assets | ---- | ---- | ---- | -4.21%306.58M | ---- | ---- | ---- | 3.28%320.05M | ---- | ---- |
| Exchange Loss (gain) | ---- | ---- | ---- | 68.13%-612.92M | ---- | ---- | ---- | 35.50%-1.92B | ---- | ---- |
| Special items | ---- | ---- | ---- | 35.15%155.22M | ---- | ---- | ---- | 95.97%114.85M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | ---- | 84.13%76.96B | ---- | ---- | ---- | -76.80%41.8B | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | -50.47%225.69M | ---- | ---- | ---- | 128.34%455.68M | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | ---- | ---- | -152.05%-1.74B | ---- | ---- | ---- | 78.19%3.34B | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | 77.29%-3.85B | ---- | ---- | ---- | -146.63%-16.96B | ---- | ---- |
| Special items for working capital changes | ---- | ---- | ---- | 93.77%-172.41M | ---- | ---- | ---- | -319.16%-2.77B | ---- | ---- |
| Cash from business operations | ---- | 29.85%27.46B | ---- | 176.16%71.42B | ---- | 31.14%21.15B | ---- | -88.14%25.86B | ---- | -86.86%16.12B |
| Other taxs | ---- | -200.06%-4.69B | ---- | 20.00%-8.6B | ---- | 77.21%-1.56B | ---- | 59.54%-10.75B | ---- | 41.51%-6.86B |
| Interest received - operating | ---- | -2.05%3.01B | ---- | -13.14%6.49B | ---- | -23.14%3.07B | ---- | 39.95%7.47B | ---- | 145.58%4B |
| Adjustment items of business operations | -22.66%39.98B | ---- | 69.49%15.06B | ---- | 151.91%51.69B | ---- | 44.43%8.89B | ---- | -87.67%20.52B | ---- |
| Net cash from operations | -22.66%39.98B | 13.78%25.78B | 69.49%15.06B | 206.91%69.31B | 151.91%51.69B | 70.83%22.65B | 44.43%8.89B | -88.52%22.58B | -87.67%20.52B | -88.22%13.26B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 65.10%9.78M | ---- | -19.09%19.43M | ---- | -54.48%5.93M | ---- | -39.92%24.02M | ---- | -62.49%13.02M |
| Dividend received - investment | 2.35%2.44B | -24.98%1.29B | 49.00%151.72M | 30.57%3.24B | 9.50%2.38B | 71.39%1.72B | 49.96%101.83M | 41.96%2.48B | 47.09%2.18B | 173.53%1B |
| Sale of fixed assets | -15.89%247.01M | -20.05%184.75M | 10.47%112.19M | -0.52%373.15M | 2.88%293.67M | 64.82%231.09M | 89.39%101.56M | -64.53%375.08M | -68.15%285.45M | -77.53%140.21M |
| Purchase of fixed assets | -8.59%-17.02B | 17.55%-9.75B | -18.56%-4.89B | -69.68%-26B | -52.05%-15.67B | -59.10%-11.83B | 12.20%-4.13B | -46.05%-15.32B | -163.86%-10.31B | -317.60%-7.43B |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -95.07%20.29M |
| Acquisition of subsidiaries | ---- | ---- | ---- | 102.18%12.22M | ---- | ---- | ---- | -279,449.75%-561.9M | -271,684.81%-546.09M | -271,587.06%-546.09M |
| Recovery of cash from investments | -11.39%35.97M | -99.61%160K | --70K | 299.84%82.98M | -84.89%40.59M | -77.07%40.51M | ---- | -97.58%20.75M | 8.27%268.71M | 351.99%176.66M |
| Cash on investment | -23.97%-3.16B | -316.71%-2.23B | -32,786.85%-2.24B | 17.49%-4.71B | 55.08%-2.55B | 90.56%-536.2M | 99.87%-6.8M | 78.30%-5.71B | -209.49%-5.68B | -14,434.48%-5.68B |
| Other items in the investment business | -99.68%34.55K | -100.10%-11K | ---- | -97.48%8.78M | 16.79%10.87M | -64.76%10.78M | -92.58%11.69M | 199.04%349.01M | -88.80%9.3M | -78.76%30.6M |
| Net cash from investment operations | -12.67%-17.46B | -1.41%-10.5B | -75.22%-6.86B | -47.05%-26.97B | -12.34%-15.49B | 15.62%-10.36B | 61.16%-3.92B | 44.38%-18.34B | -415.58%-13.79B | -6,058.04%-12.27B |
| Net cash before financing | -37.78%22.52B | 24.21%15.28B | 64.96%8.2B | 898.21%42.34B | 438.06%36.2B | 1,144.41%12.3B | 226.40%4.97B | -97.41%4.24B | -95.89%6.73B | -99.12%988.32M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -57.46%2.68B | -59.93%2.34B | 101.68%2.34B | -14.37%8.54B | -10.40%6.31B | 38.55%5.85B | -52.71%1.16B | 39.74%9.98B | 48.35%7.04B | 19.97%4.22B |
| Refund | 77.34%-3.67B | 82.11%-2.55B | 77.47%-2.14B | -63.13%-17.48B | -77.83%-16.21B | -167.31%-14.23B | -217.97%-9.49B | 74.34%-10.71B | 69.39%-9.12B | 80.56%-5.32B |
| Issuing shares | ---- | -57.61%1.31M | ---- | -95.75%3.3M | ---- | -95.91%3.08M | ---- | -57.25%77.66M | ---- | 2,620.75%75.39M |
| Interest paid - financing | ---- | 18.63%-832.35M | ---- | 12.02%-1.96B | ---- | -0.81%-1.02B | ---- | -17.31%-2.22B | ---- | -59.54%-1.01B |
| Dividends paid - financing | -239.33%-19.51B | -327.94%-18.12B | 33.41%-416.28M | 64.59%-13.91B | 81.51%-5.75B | 85.54%-4.23B | 38.20%-625.14M | 33.74%-39.29B | -53.54%-31.1B | -86.43%-29.27B |
| Absorb investment income | -43.74%54.1M | ---- | 1,941.24%1.99M | ---- | 17.36%96.17M | ---- | -92.66%97.58K | ---- | -68.10%81.94M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | -897.98%-4.19B | ---- | -60.00%-2.02B | ---- | ---419.76M | ---- | ---1.26B | ---- | ---- |
| Other items of the financing business | -33.43%-15B | 94.31%-48.24M | -31.84%-5.48B | 67.60%-656.62M | 17.69%-11.24B | 44.53%-847.6M | 27.59%-4.15B | 57.10%-2.03B | 2.32%-13.65B | -1,294.09%-1.53B |
| Net cash from financing operations | -32.25%-35.44B | -41.25%-30.37B | 56.63%-5.69B | 32.33%-40.62B | 42.68%-26.8B | 47.82%-21.5B | -80.19%-13.11B | 47.97%-60.03B | 20.79%-46.75B | 13.71%-41.2B |
| Effect of rate | 42.11%-713.51M | -90.19%44.26M | -102.56%-2.55M | 3.09%1.3B | -156.51%-1.23B | -84.01%451.19M | 104.75%99.59M | -85.55%1.26B | -83.21%2.18B | -39.18%2.82B |
| Net Cash | -237.37%-12.92B | -64.03%-15.09B | 130.86%2.51B | 103.09%1.72B | 123.49%9.4B | 77.12%-9.2B | 27.37%-8.14B | -215.16%-55.79B | -138.20%-40.02B | -162.21%-40.21B |
| Begining period cash | 1.67%184.19B | 1.67%184.19B | 1.67%184.19B | -23.13%181.17B | -23.13%181.17B | -23.11%181.17B | -23.11%181.17B | 32.09%235.69B | 32.09%235.69B | 32.05%235.61B |
| Cash at the end | -9.92%170.56B | -1.90%169.14B | 7.84%186.7B | 1.67%184.19B | -4.30%189.34B | -13.02%172.42B | -22.12%173.12B | -23.11%181.17B | -33.20%197.85B | -19.97%198.23B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Shin Yong Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.